DISCLOSEDQuarterly
Renaissance Technologies
Lineage Cell Therapeutics In · NASDAQ
2,125,100 sh · $3.4M
Filed 31 Mar 2026SEC 13Fview source
Renaissance Technologies
Lineage Cell Therapeutics In · NASDAQ
2,125,100 sh · $3.4M
Two Sigma Investments
Lineage Cell Therapeutics In · NASDAQ
88,585 sh · $140.0K
BlackRock
Lineage Cell Therapeutics In · NASDAQ
9,559,466 sh · $9.5M